Products

What will AGI do for Azelaic acid?

This classification denotes an anti-infective agent with the molecular formula C9H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F2VW3D43YT, chemically known as 1,9-nonanedioic acid but more generally known as azelaic acid, which bears US NIH Compound Identifier 2266. European Medicines Agency schedules Azelaic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05648MIG. The term AZELAIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules azelaic acid in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule azelaic acid under HS 29171390 and SITC 51389. As of Q4 2014, AZELAIC ACID remains US FDA's Preferred Term for this commodity. Azelaic acid bears US NLM identifiers UMLS ID C0052761 and NCI Concept Code C47407. SMILES: C(CCCC(=O)O)CCCC(=O)O.

How AGI delivers it

Four ways AGI delivers for Azelaic acid

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Azelaic acid, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Azelaic acid, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Azelaic acid connects

measured by

  • Acid Valuemodel
  • Assay Puritymodel
  • Color (APHA)model
  • Color Indexmodel
  • Compound Puritymodel
  • Melting Pointmodel